To perform a cost-effectiveness analysis of high-intensity interval training (HIIT) compared with moderate intensity steady-state (MISS) training in people with coronary artery disease (CAD) attending cardiac rehabilitation (CR). Secondary cost-effectiveness analysis of a prospective, assessor-blind, parallel group, multi-center RCT. Six outpatient National Health Service cardiac rehabilitation centers in England and Wales, UK. 382 participants with CAD (n = 382). Participants were randomized to twice-weekly usual care (n = 195) or HIIT (n = 187) for 8 weeks. Usual care was moderate intensity continuous exercise (60% to 80% maximum capacity, MISS), while HIIT consisted of 10 x 1-minute intervals of vigorous exercise (> 85% maximum capacity) interspersed with 1-minute periods of recovery. We conducted a cost-effectiveness analysis of the HIIT or MISS UK trial. Health related quality of life was measured with the EQ-5D-5L to estimate quality-adjusted life years (QALYs). Costs were estimated with health service resource use and intervention delivery costs. Cost-utility analysis measured the incremental cost-effectiveness ratio (ICER). Bootstrapping assessed the probability of HIIT being cost-effective according to the UK National Institute for Health and Care Excellence (NICE) threshold value (20,000 pounds per QALY). Missing data were imputed. Uncertainty was estimated using probabilistic sensitivity analysis. Assumptions were tested using univariate/1-way sensitivity analysis. 124 (HIIT, n = 59; MISS, n = 65) participants completed questionnaires at baseline, 8 weeks, and 12 months. Mean combined health care use and delivery cost was 676 pounds per participant for HIIT, and 653 pounds for MISS. QALY changes were 0.003 and -0.013, respectively. For complete cases, the ICER was 1448 pounds per QALY for HIIT compared with MISS. At a willingness-to-pay threshold of 20,000 pounds per QALY, the probability of HIIT being cost-effective was 96% (95% CI 0.90 to 0.95). For people with CAD attending CR, HIIT was cost-effective compared with MISS. These findings are important to policy makers, commissioners, and service providers across the health care sector.

Full text (sometimes free) may be available at these link(s):      help

• DOI
• PubMed
• PDF locator
• publisher